国产a级特黄的片子,精品香蕉一区二区三区,亚洲精品99久久久久中文字幕,无码精品A∨在线观看无广告

Taloph Pharmaceutical Co., Ltd. issued an announcement, Zhengzhou Marine Biopharmaceutical Technology Co., Ltd., a subsidiary of Beijing Leadingpharm Pharmaceutical Technology Development Co., Ltd., intends to increase its capital by 30 million yuan to Zhengzhou Transmed Biotechnology Co., Ltd., which is engaged in biomedical CDMO business.

Recently, Leadingpharm Analysis and Testing Center has obtained the laboratory accreditation certificate awarded by the China National Accreditation Service for Conformity Assessment (CNAS), which indicates that the company's analytical testing ability and corresponding quality management system have been recognized by international and domestic authorities and can provide customers with more professional and quality services, as well as assurance to product quality control and new drug research.

On April 6th, 2021, the annual summary meeting of strategic cooperation between Leadingpharm and HealthShare was successfully held.

From March 25 to 27, 2021, the 14th China Pharmaceutical Industry Development Summit Forum and the 10th Anniversary Celebration of 2010-2020 of Pharmaceutical Industry Chamber of Commerce of ACFIC was held in Sanya. Nearly 1,000 representatives of entrepreneurs and scientists from all over China attended this grand event.

In the morning of March 19th, Professor Lu Zhonglin, Party Secretary of School of Chemistry, Beijing Normal University, Professor Yang Qingzheng, Vice President, Mr,Zheng Baofu, Chairman and General Manager of Shanghai Haoyuan Pharmaceutical, Peng Lijun, Chief Operating Officer, and other experts and leaders visited Leadingpharm.